MeSH tree: C15.378.508
A cancer cell behaves differently from a healthy cell, with unique features that enable rapid growth and bypass quality controls. Rice University's Natasha Kirienko is interested in finding these unique features and exploiting ...
Sep 18, 2026
0
7
Multiparametric flow cytometry—a test that is widely accessible, cost-effective and timely—can find one cancerous cell hidden among thousands of healthy cells following treatment for acute myeloid leukemia.
Sep 15, 2026
0
6
In a new study, researchers from King's College London trained AI models on multiple types of clinical and biological data to determine whether they could predict which patients with acute myeloid leukemia (AML) would respond ...
Sep 10, 2026
0
4
Cells have all kinds of intricate machinery to control genes, switching them on and off at the right times and under the right conditions. Components of this machinery include chromatin-modifying complexes, groups of proteins ...
Sep 10, 2026
0
9
Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at the University of Gothenburg are using this approach to treat leukemia. A new drug forces cancer cells to keep working hard ...
Sep 8, 2026
0
7
Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published in the journal Therapeutic ...
Sep 7, 2026
0
6
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice ...
Sep 2, 2026
0
7
Over the past 75 years, advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States, according to results of an analysis led by researchers at Blood Cancer United and ...
Sep 1, 2026
0
4
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients ...
Aug 10, 2026
0
6
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells. Researchers at Baylor College ...
Aug 7, 2026
0
10
